Navigation Links
New computer simulation helps explain folding in important cellular protein
Date:7/29/2009

Athens, Ga. Most parts of living organisms come packaged with ribbons. The ribbons are proteinschains of amino acids that must fold into three-dimensional structures to work properly. But when for any reason the ribbons fold incorrectly, bad things can happen, and in humans misfolded-protein disorders include Alzheimer's and Parkinson's diseases.

Scientists have for the past three decades tried to understand what makes proteins fold into functional units and why it happens, and several breakthroughs have occurred through computer modelinga field that dramatically increases analytical speed.

Now, scientists at the University of Georgia have created a two-step computer simulation (using an important process called the Wang-Landau algorithm) that sheds light on how a crucial proteinglycophorin Abecomes an active part of living cells. The new use of Wang-Landau could lead to a better understanding of the controlling mechanisms behind protein folding.

"Our goal is to present the methodology in a clear, self-consistent way, accessible to any scientist with knowledge of Monte Carlo simulations," said David Landau, distinguished research professor of physics at the University of Georgia and director of the Center for Simulational Physics.

The research was just published in The Journal of Chemical Physics. Authors of the paper are Clare Gervais and Thomas Wst, formerly of UGA and now employed in Switzerland; Landau, and Ying Xu, Regents-Georgia Research Alliance Eminent Scholar and professor of bioinformatics and computational biology, also at UGA. The research was supported by grants from the National Institutes of Health and the National Science Foundation. Landau and Xu are in UGA's Franklin College of Arts and Sciences.

"This work demonstrates the power and potential of combining expertise from computational physics and computational biology in solving challenging biological problems," said Xu.

Monte Carlo simulationsthe use of algorithms with repeated random samplings to produce reliable predictionshave been around for some decades but have been steadily refined. These simulations are useful for extremely complex problems with multiple variables, and though they often require considerable computer "brain power," they are able to give scientists startlingly accurate predictions of how biological processes work.

In the current paper, the research team developed a two-step Monte Carlo procedure to investigate, for glycophorin A (GpA), an important biochemical process called dimerization. (A dimer in biology or chemistry consists of two structurally similar units that are held together by intra- or intermolecular forces.)

"One particularly promising approach is to investigate the thermodynamics of protein folding through examining the energy landscape," Landau explained. "By doing this, we can learn about the characteristics of proteins including possible folding pathways and folding intermediates. Thus, it allows us to bridge the gap between statistical and experimental results."

Unfortunately, so much is happening physically and biochemically as proteins fold into their functional shapes (called the native state) that the problems must be broken down one by one and studied. That led the team to a question: Could they use a Monte Carlo Simulation along with the Wang-Landau algorithm to discover an efficient simulation method capable of sampling the energy density states that allow such folding?

Perhaps remarkably, they did. The first step in studying the dimerization process was to estimate those states in GpA using Wang-Landau. The second step was to sample various energy and structural "observables" of the system to provide insights into the thermodynamics of the entire system.

The results could be broadly applied to many fields of protein-folding studies that are important to understandingand treatingcertain diseases. (Wang-Landau, named for David Landau and Fugao Wang, is a Monte Carlo algorithm that has proved to be useful in studying a variety of physical systems. Wang was a doctoral student at UGA and now works for the Intel Corp.)

GpA is a 131-amino acid protein that spans the human red-blood cell membrane and is crucial in cell procedures. Because it has been studied in depth for many years, it also serves as an important model system for how similar systems work. That's why the new simulation may open doors in many other areas of inquiry.

"The main advantage of this two-step approach lies in its flexibility as well as its generality," said Landau. "This method is widely applicable to any study of biological systems, such as the folding process of soluble proteins, polymers, DNA or protein complexes. Therefore, it is an excellent alternative to other simulation methods used traditionally in the field of protein-folding thermodynamics."

In the current study, the team discovered something generally important about membrane proteins in general, too. They found that unlike some proteins for which folding is mainly governed by their attraction to or repulsion by water, the process in GpA is driven by a subtle interplay between multiple types of interactions.


'/>"/>

Contact: David Landau
dlandau@uga.edu
706-542-2908
University of Georgia
Source:Eurekalert

Related biology news :

1. New supercomputer to reel in answers to some of Earths problems
2. Computers aid in cracking deception in plants
3. Brain-computer interface, developed at Brown, begins new clinical trial
4. Computer model predicts brain tumor growth and evolution
5. Caltech researchers train computers to analyze fruit-fly behavior
6. Collaboration leads to success: Most powerful computer of its kind in western N.Y. available worldwide
7. Computer simulations explain the limitations of working memory
8. Computer superpower strengthens attempts to combat common diseases
9. New open-source software permits faster desktop computer simulations of molecular motion
10. Lifecycles of tropical cyclones predicted in global computer model
11. Singapore research team first place in Brain-Computer Interface contest
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/13/2017)... Feb. 13, 2017  RSA Conference -- RSA, a ... is designed to enhance fraud detection and investigation ... the RSA Fraud & Risk Intelligence Suite. The ... leverage additional insights from internal and external sources ... protect their customers from targeted cybercrime attacks. ...
(Date:2/8/2017)... Feb. 7, 2017  Aware, Inc. (NASDAQ: AWRE ... reported financial results for its quarter and year ended December ... of 2016 was $3.9 million compared to $6.9 million in ... quarter of 2016 was $0.6 million compared to $2.6 million ... fourth quarter of 2016 was $0.5 million, or $0.02 per ...
(Date:2/7/2017)... Feb. 7, 2017 Zimmer Biomet Holdings, Inc. ... healthcare, will present at the LEERINK Partners 6th Annual ... Hotel on Wednesday, February 15, 2017 at 10 a.m. ... the presentation can be accessed at http://wsw.com/webcast/leerink28/zbh .  ... conference via Zimmer Biomet,s Investor Relations website at ...
Breaking Biology News(10 mins):
(Date:2/16/2017)... DUBLIN , Feb. 16, 2017 ... the "Synthetic Biology: Global Markets" report to ... ... synthetic-biology products (synthetic genes, biobrick parts, delivery plasmids, chassis ... DNA synthesis and assembly, genome editing, bioinformatics and specialty ...
(Date:2/16/2017)... PALM BEACH, Florida , February 16, 2017 ... vastly improving with the infusion of innovative telemedicine ... patient monitoring services that are experiencing a boom ... evolve with the advancement of technologies, services and ... Technologies Inc. (OTC: RQHTF) (TSX-V: RHT), Cellectar Biosciences, ...
(Date:2/16/2017)... N.J. , Feb. 16, 2017  Champions Oncology, ... in the development and sale of advanced technology solutions ... oncology drugs, today announced the addition of new cohorts ... These new models will expand Champions, product line ... head and neck cancer, AML, and non-small cell lung ...
(Date:2/16/2017)... Feb. 16, 2017  Rhythm, a biopharmaceutical ... deficiencies that result in life-threatening metabolic disorders, ... million mezzanine round of financing with existing ... Capital, New Enterprise Associates, Pfizer Venture Investments, ... healthcare investment fund. Rhythm will use the ...
Breaking Biology Technology: